Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC


Antonia S. J. , Villegas A., Daniel D., Vicente D., Murakami S., Hui R., ...More

NEW ENGLAND JOURNAL OF MEDICINE, vol.379, no.24, pp.2342-2350, 2018 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 379 Issue: 24
  • Publication Date: 2018
  • Doi Number: 10.1056/nejmoa1809697
  • Journal Name: NEW ENGLAND JOURNAL OF MEDICINE
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.2342-2350

Abstract

BACKGROUND